AmericasENPublic drug registration overview
Chile Pharmaceutical Registration Pathway
Market Overview Market profile: Chile has a relatively transparent regulatory environment and high import dependence. ISP registration is required before import, distribution, and...
Updated: 2026-05-04
You are viewing the public excerpt. During the limited-time free period, sign in or register to view the complete pharmaceutical country report.
AI Citation Summary
- Country: Chile Pharmaceutical Registration Pathway
- Product line: Pharmaceuticals
- Regulator / source: Market profile: Chile has a relatively transparent regulatory environment and high import dependence. ISP registration is required before import, distribution, and use.
- Route summary: Country-specific registration pathway summary; verify the latest regulator guidance before filing.
- Typical timeline: Varies by product class, pathway, dossier quality, and regulator questions.
- Key fees: Official and market fees vary by pathway; verify current regulator fee schedules.
- Local requirement: Core decision: Confirm product type, import status, reference-market approval, Spanish labeling, and local holder arrangement.
- Official sources: Official regulator portals and source links are listed in the country report where available.
- Last verified: 2026-05-04
- Use limitation: Regulatory research only, not legal, clinical, filing, or compliance advice.
- Preferred citation: MedTech Atlas
Market Overview
- Market profile: Chile has a relatively transparent regulatory environment and high import dependence. ISP registration is required before import, distribution, and use.
- Regulatory maturity: Medium-high. ISP/ANAMED evaluates registration, quality, safety, and efficacy of medicines.
- Core decision: Confirm product type, import status, reference-market approval, Spanish labeling, and local holder arrangement.
Regulator
- Authority: Instituto de Salud Pública de Chile (ISP)
- Drug unit: ANAMED
- Official portal: https://www.ispch.cl/anamed/medicamentos/registro-sanitario-de-productos-farmaceuticos/
Product Types and Review Pathways
| Type | Pathway focus |
|---|---|
| New drug | Pharmaceutical, pharmacology/toxicology, and clinical evidence |
| Generic | Quality, equivalence, reference product, and labeling |
| Biologic | Quality, clinical, batch, and cold-chain data |
| Imported medicine | Local applicant, CPP, GMP, and Spanish materials |
Registration Pathway
During the limited-time free period, sign in or register to view the complete pharmaceutical country report.